The effect of pramipexole extended release on the levodopa equivalent daily dose in Lebanese Parkinson diseased patients

• Päätekijät: Faddoul L (Tekijä), Chahine B (Tekijä), Haydar S (Tekijä), Abourida S (Tekijä), Hallit S (Tekijä), Bou Raad E. (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Centro de Investigaciones y Publicaciones Farmaceuticas, 2018-12-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Objective: The objective of this study is to compute the potential benefit of Pramipexole ER on total levodopa equivalent dose (LED) and Unified Parkinson Disease Rating Score (UPDRS-III) compared to mono- or combined therapy of pramipexole IR and/or carbidopa/levodopa. Methods: This is a retrospect...